Rabia Malik v. HHS - Tdap, Guillain-Barré Syndrome (2022)

On August 3, 2018, Rabia Malik filed a petition for compensation under the National Vaccine Injury Compensation Program. Petitioner alleged that she developed Guillain-Barré Syndrome (GBS) after receiving a tetanus, diphtheria, acellular pertussis (Tdap) vaccine on September 25, 2015.

The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused petitioner's alleged injury or her current condition. The parties reached a settlement agreement, and on August 11, 2022, they filed a joint stipulation outlining the terms.

As part of the settlement, the respondent agreed to pay Ms. Malik a lump sum of $308,024.00, payable by check to Rabia Malik.

This amount was intended to compensate for all damages available under the program. Special Master Mindy Michaels Roth adopted the parties' stipulation and awarded compensation in the agreed-upon amount and terms.

The clerk of court was directed to enter judgment accordingly. The decision was designated "unpublished" but posted on the Court of Federal Claims' website in accordance with the E-Government Act of 2002, with parties having the option to request redaction of confidential information.